Back to Search
Start Over
Dextromethorphan: a review of N-methyl-d-aspartate receptor antagonist in the management of pain.
- Source :
-
CNS drug reviews [CNS Drug Rev] 2007 Spring; Vol. 13 (1), pp. 96-106. - Publication Year :
- 2007
-
Abstract
- Dextromethorphan (DM) is a noncompetitive N-methyl-d-aspartate (NMDA) receptor antagonist, which is widely used as an antitussive agent. DM also prevents neuronal damage and modulates pain sensation via noncompetitive antagonism of excitatory amino acids (EAAs). DM has been found to be useful in the treatment of pain in cancer patients and in the treatment of methotrexate-induced neurotoxicity. Clinical studies with DM in cancer patients are reviewed in this article.
- Subjects :
- Animals
Clinical Trials as Topic
Dextromethorphan pharmacology
Excitatory Amino Acid Antagonists pharmacology
Humans
Pain classification
Receptors, N-Methyl-D-Aspartate physiology
Dextromethorphan therapeutic use
Excitatory Amino Acid Antagonists therapeutic use
Pain drug therapy
Receptors, N-Methyl-D-Aspartate antagonists & inhibitors
Subjects
Details
- Language :
- English
- ISSN :
- 1080-563X
- Volume :
- 13
- Issue :
- 1
- Database :
- MEDLINE
- Journal :
- CNS drug reviews
- Publication Type :
- Academic Journal
- Accession number :
- 17461892
- Full Text :
- https://doi.org/10.1111/j.1527-3458.2007.00006.x